We are live on ! Find out more
ABMD

Abiomed Inc
ABMD

Delisted

ABMD was delisted on the 21st of December, 2022.

Back to rankings

474 hedge funds and large institutions have $13B invested in Abiomed Inc in 2021 Q2 according to their latest regulatory filings, with 41 funds opening new positions, 163 increasing their positions, 179 reducing their positions, and 49 closing their positions.

New
Increased
Maintained
Reduced
Closed

71% more call options, than puts

Call options by funds: $106M | Put options by funds: $61.8M

1% less capital invested

Capital invested by funds: $13.1B → $13B (-$186M)

9% less repeat investments, than reductions

Existing positions increased: 163 | Existing positions reduced: 179

3% less funds holding

Funds holding: 487 → 474 (-13)

16% less first-time investments, than exits

New positions opened: 41 | Existing positions closed: 49

50% less funds holding in top 10

Funds holding in top 10: 4 → 2 (-2)

Holders
474
Holders Change
-13
Holders Change %
-2.67%
% of All Funds
8.25%
Holding in Top 10
2
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-50%
% of All Funds
0.03%
New
41
Increased
163
Reduced
179
Closed
49
Calls
$106M
Puts
$61.8M
Net Calls
+$44M
Net Calls Change
+$5.37M

Top Buyers

1
OCBV
Ownership Capital B.V.
Netherlands
+$185M
2
Macquarie Group
Macquarie Group
Australia
+$145M
3
Baillie Gifford & Co
Baillie Gifford & Co
United Kingdom
+$58.6M
4
HSBC Holdings
HSBC Holdings
United Kingdom
+$24.9M
5
Two Sigma Advisers
Two Sigma Advisers
New York
+$22.3M

Top Sellers

1
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$46.4M
2
APM
Avidity Partners Management
Texas
-$42.2M
3
JSP
Jackson Square Partners
California
-$38.3M
4
Renaissance Technologies
Renaissance Technologies
New York
-$31M
5
Wells Fargo
Wells Fargo
California
-$29M
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$1.52B +$21.7M +70,871 +1%
BlackRock
2
BlackRock
New York
$1.31B +$16.5M +53,668 +1%
Baillie Gifford & Co
3
Baillie Gifford & Co
United Kingdom
$1.13B +$58.6M +191,084 +6%
Wellington Management Group
4
Wellington Management Group
Massachusetts
$651M +$11M +35,768 +2%
State Street
5
State Street
Massachusetts
$610M +$17.3M +56,338 +3%
Primecap Management
6
Primecap Management
California
$580M -$18.8M -61,280 -3%
Renaissance Technologies
7
Renaissance Technologies
New York
$524M -$31M -101,200 -6%
BCM
8
Brown Capital Management
Maryland
$481M -$18.4M -60,077 -4%
William Blair Investment Management
9
William Blair Investment Management
Illinois
$291M -$1.41M -4,583 -0.5%
CS
10
Credit Suisse
Switzerland
$266M -$16.3M -53,204 -6%
AllianceBernstein
11
AllianceBernstein
Tennessee
$262M +$7.82M +25,478 +3%
Geode Capital Management
12
Geode Capital Management
Massachusetts
$247M +$4.95M +16,151 +2%
Bank of New York Mellon
13
Bank of New York Mellon
New York
$215M +$807K +2,632 +0.4%
Invesco
14
Invesco
Georgia
$191M +$1.35M +4,388 +0.7%
OCBV
15
Ownership Capital B.V.
Netherlands
$189M +$185M +604,177 New
Ameriprise
16
Ameriprise
Minnesota
$189M -$3.79M -12,366 -2%
JP Morgan Chase
17
JP Morgan Chase
New York
$187M +$9.5M +30,972 +5%
PAI
18
Palo Alto Investors
California
$182M +$2.67M +8,700 +2%
Northern Trust
19
Northern Trust
Illinois
$158M +$4.03M +13,123 +3%
Macquarie Group
20
Macquarie Group
Australia
$151M +$145M +472,508 +4,428%
JSP
21
Jackson Square Partners
California
$140M -$38.3M -124,975 -22%
William Blair & Company
22
William Blair & Company
Illinois
$132M +$5.36M +17,456 +4%
Norges Bank
23
Norges Bank
Norway
$120M -$1.02M -3,340 -0.9%
Legal & General Group
24
Legal & General Group
United Kingdom
$112M +$21.4M +69,825 +24%
Wells Fargo
25
Wells Fargo
California
$110M -$29M -94,680 -21%
1
2 3 4 5

ABMD Hedge Fund Activity: Q2 2021 in Review

474 of the 5,745 institutional investors tracked by Wall St. Rank reported a position in Abiomed Inc (ABMD) for Q2 2021, worth a combined $13B — down 1.4% from $13.1B a quarter earlier.

Sellers outnumbered buyers: 49 funds closed out of ABMD and 41 opened new positions — a net loss of 8 holders — while 179 trimmed existing stakes and 163 added.

The largest buyer was Ownership Capital B.V., opening a new position worth an estimated $185M. The largest seller was Adage Capital Partners, cutting an estimated $46.4M.

  • 474 institutional investors held Abiomed Inc (ABMD) as of Q2 2021, down from 487 in Q1 2021.
  • Funds reported $13B of Abiomed Inc stock for Q2 2021, down 1.4% quarter-over-quarter.
  • 41 funds opened new Abiomed Inc positions in Q2 2021 and 49 closed out, a net change of -8 holders.
  • The largest Abiomed Inc buyer in Q2 2021 was Ownership Capital B.V., an estimated $185M added.
  • The largest Abiomed Inc seller in Q2 2021 was Adage Capital Partners, an estimated $46.4M sold.

Based on aggregated 13F filings for Q2 2021.